By Barbara J. Gitlitz, MD, Stephen V. Liu, MD

Articles by By Barbara J. Gitlitz, MD, Stephen V. Liu, MD

USC Works With "Dream Team" to Deliver Promise of Epigenetic Therapy to Clinical Practice

ByBy Barbara J. Gitlitz, MD, Stephen V. Liu, MD,Peter A. Jones, PhD, DSc

April 29th 2013

Barbara J. Gitlitz, MD, Stephen V. Liu, MD, and Peter A. Jones, PhD, DSc, from the USC Norris Comprehensive Cancer Center, describe efforts to translate promising epigenetic research into clinical practice.

Latest Updated Articles

USC Works With "Dream Team" to Deliver Promise of Epigenetic Therapy to Clinical Practice
Published: April 29th 2013 | Updated:

By Barbara J. Gitlitz, MD, Stephen V. Liu, MD

Articles by By Barbara J. Gitlitz, MD, Stephen V. Liu, MD

USC Works With "Dream Team" to Deliver Promise of Epigenetic Therapy to Clinical Practice

Latest Updated Articles

Trending on OncLive

Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma

Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma

FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care

FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL

Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies